Rapid Point-of-Care NT-proBNP Optimal Cut-off Point for Heart Failure Diagnosis in Primary Care

2012 ◽  
Vol 65 (7) ◽  
pp. 613-619 ◽  
Author(s):  
José M. Verdú ◽  
Josep Comín-Colet ◽  
Mar Domingo ◽  
Josep Lupón ◽  
Miguel Gómez ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Point Of Care ◽  
Failure Diagnosis ◽  
Heart Failure Diagnosis

scholarly journals NT-proBNP for heart failure diagnosis in Primary Care: Costs or savings? A budget impact study

2021 ◽  
Author(s):  
Cândida Fonseca ◽  
Paulo Bettencourt ◽  
Dulce Brito ◽  
Helena Febra ◽  
Álvaro Pereira ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Budget Impact ◽  
Failure Diagnosis ◽  
Impact Study ◽  
Heart Failure Diagnosis ◽  
Care Costs

Association of depression and anxiety with adherence in primary care patients with heart failure—cross-sectional results of the observational RECODE-HF cohort study

2020 ◽  
Vol 37 (5) ◽  
pp. 695-702 ◽  
Author(s):  
Marion Eisele ◽  
Malte Harder ◽  
Anja Rakebrandt ◽  
Sigrid Boczor ◽  
Gabriella Marx ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Care ◽  
Cohort Study ◽  
Psychological Distress ◽  
Medication Adherence ◽  
Failure Diagnosis ◽  
Cross Sectional ◽  
Factors Associated ◽  
Patients With Heart Failure ◽  
Heart Failure Diagnosis

Abstract Background Psychological distress has a negative impact on the prognosis and quality of life for patients with heart failure. We investigated the association between psychological distress and the patients’ adherence to medical treatment (medication adherence) and self-care advice (lifestyle adherence) in heart failure. We further examined whether there are different factors associated with low medication compared to low lifestyle adherence. Method This secondary analysis of the RECODE-HF cohort study analyzed baseline data of 3099 primary care heart failure patients aged 74 ± 10 years, 44.5 % female. Using multivariable regression, factors relating to medication and lifestyle adherence were investigated in order to estimate the extent to which these factors confound the association between psychological distress and adherence. Results Psychological distress was significantly associated with poorer medication adherence but not with lifestyle adherence after controlling for confounders. We identified different factors associated with medication compared to lifestyle adherence. A higher body mass index, a less developed social network, living alone, fewer chronic co-morbidities and unawareness of the heart failure diagnosis were only related to lower lifestyle adherence. Higher education was associated with poorer medication adherence. Male sex, younger age, lower self-efficacy and less familiar relation with the general practitioner were common factors associated with both lower medication and lifestyle adherence. Conclusion Promising factors for increasing medication adherence (reduction of psychological distress) and lifestyle adherence (explaining the patient his/her heart failure diagnosis more than once and increase in the patients’ self-efficacy), which were found in this cross-sectional study, must be further investigated in longitudinal studies.

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽  
2018 ◽  
pp. 1778-1781
Author(s):  
Christian Mueller
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Natriuretic Peptide ◽  
Natriuretic Peptides ◽  
Point Of Care ◽  
Failure Diagnosis ◽  
Central Laboratory ◽  
Important Advance ◽  
Cardiac Stress ◽  
Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽  
2018 ◽  
pp. 1778-1781
Author(s):  
Christian Mueller
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Natriuretic Peptide ◽  
Natriuretic Peptides ◽  
Point Of Care ◽  
Failure Diagnosis ◽  
Central Laboratory ◽  
Important Advance ◽  
Cardiac Stress ◽  
Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽  
2018 ◽  
pp. 1778-1781
Author(s):  
Christian Mueller
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Natriuretic Peptide ◽  
Natriuretic Peptides ◽  
Point Of Care ◽  
Failure Diagnosis ◽  
Central Laboratory ◽  
Important Advance ◽  
Cardiac Stress ◽  
Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Sign in / Sign up

Export Citation Format

Share Document